Triumeq
(SRMOJRAUYXTFJA-RAKRLELNSA-N)
Structure
- SMILES
- Nc1ccn(c(=O)n1)[C@@H]1CS[C@@H](O1)CO.Fc1ccc(c(c1)F)CNC(=O)c1cn2C[C@@H]3OCC[C@H](N3C(=O)c2c(c1=O)O)C.OC[C@@H]1C=C[C@@H](C1)n1cnc2c1nc(N)nc2NC1CC1
- Molecular Formula:
- C42H48F2N12O9S
- Molecular Weight:
- 934.967
- Log P:
- 3.4152
- Hydrogen Bond Acceptor:
- 22
- Hydrogen Bond Donor:
- 7
- TPSA:
- 318.42
- CAS Number(s):
- 1319715-09-7
Synonym(s)
1.
Triumeq
External Link(s)
| PubChem Compound | 54736666 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Nausea | FAERS: 99 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 2 | Drug dose omission | FAERS: 92 | US FAERS | |
| 3 | Headache | FAERS: 87 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 4 | Product dose omission | FAERS: 73 | US FAERS | |
| 5 | Fatigue | FAERS: 64 | US FAERS | |
| 6 | Malaise | FAERS: 48 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Vomiting | FAERS: 43 | US FAERS | |
| 8 | Anxiety | FAERS: 40 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Hypersensitivity | FAERS: 35 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Abdominal discomfort | FAERS: 28 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 11 | Arthralgia | FAERS: 28 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | Asthenia | FAERS: 27 | US FAERS | |
| 13 | Dizziness | FAERS: 27 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Myalgia | FAERS: 27 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 15 | Myocardial Infarction | FAERS: 26 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 16 | Drug ineffective | FAERS: 24 | US FAERS | |
| 17 | Abdominal Pain | FAERS: 23 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 18 | Pain | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 19 | Pruritus | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 20 | Feeling abnormal | FAERS: 19 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 21 | Viral load increased | FAERS: 19 | US FAERS | |
| 22 | Blood creatinine increased | FAERS: 17 | US FAERS | |
| 23 | Chills | FAERS: 17 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 24 | Palpitations | FAERS: 16 | US FAERS | |
| 25 | Constipation | FAERS: 13 | US FAERS | |
| 26 | Pneumonia | FAERS: 13 | US FAERS | |
| 27 | Blood glucose increased | FAERS: 12 | US FAERS | |
| 28 | Nasopharyngitis | FAERS: 12 | US FAERS | |
| 29 | Oropharyngeal pain | FAERS: 12 | US FAERS | |
| 30 | Pancreatitis | FAERS: 12 | US FAERS | |
| 31 | Weight decreased | FAERS: 12 | US FAERS | |
| 32 | Alopecia | FAERS: 11 | US FAERS | |
| 33 | Back Pain | FAERS: 11 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 34 | Blood HIV RNA increased | FAERS: 11 | US FAERS | |
| 35 | Drug resistance | FAERS: 11 | US FAERS | |
| 36 | Immune Reconstitution Inflammatory Syndrome | FAERS: 11 | US FAERS | |
| 37 | Inability to afford medication | FAERS: 11 | US FAERS | |
| 38 | Product storage error | FAERS: 11 | US FAERS | |
| 39 | Product availability issue | FAERS: 10 | US FAERS | |
| 40 | Cerebrovascular accident | FAERS: 9 | US FAERS | |
| 41 | Chest Pain | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 42 | Flatulence | FAERS: 9 | US FAERS | |
| 43 | jaundice | FAERS: 9 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 44 | Depressed mood | FAERS: 8 | US FAERS | |
| 45 | Diabetes Mellitus | FAERS: 8 | US FAERS | |
| 46 | Dyspepsia | FAERS: 8 | US FAERS | |
| 47 | Tremor | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 48 | Adverse event | FAERS: 7 | US FAERS | |
| 49 | Agitation | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 50 | Impaired work ability | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 51 | Memory impairment | FAERS: 7 | US FAERS | |
| 52 | Neutropenia | FAERS: 7 | US FAERS | |
| 53 | Night sweats | FAERS: 7 | US FAERS | |
| 54 | Suicide attempt | FAERS: 7 | US FAERS | |
| 55 | Therapy cessation | FAERS: 7 | US FAERS | |
| 56 | Wrong technique in product usage process | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 57 | CD4 Lymphocytes Decreased | FAERS: 6 | US FAERS | |
| 58 | Hepatitis | FAERS: 6 | US FAERS | |
| 59 | Infarction | FAERS: 6 | US FAERS | |
| 60 | Lymphadenopathy | FAERS: 6 | US FAERS | |
| 61 | Urticaria | FAERS: 6 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 62 | nervous system disorder | FAERS: 6 | US FAERS | |
| 63 | Acute myocardial infarction | FAERS: 5 | US FAERS | |
| 64 | Alanine Aminotransferase Increased | FAERS: 5 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 65 | Aspartate Aminotransferase Increased | FAERS: 5 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 66 | Blood cholesterol increased | FAERS: 5 | US FAERS | |
| 67 | Blood creatine phosphokinase increased | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 68 | Bone pain | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 69 | Bronchitis | FAERS: 5 | US FAERS | |
| 70 | Completed Suicide | FAERS: 5 | US FAERS | |
| 71 | Drug administered to patient of inappropriate age | FAERS: 5 | US FAERS | |
| 72 | Drug dispensing error | FAERS: 5 | US FAERS | |
| 73 | Drug screen positive | FAERS: 5 | US FAERS | |
| 74 | Hypotension | FAERS: 5 | US FAERS | |
| 75 | Influenza | FAERS: 5 | US FAERS | |
| 76 | Lethargy | FAERS: 5 | US FAERS | |
| 77 | Musculoskeletal Pain | FAERS: 5 | US FAERS | |
| 78 | Myocarditis | FAERS: 5 | US FAERS | |
| 79 | Somnolence | FAERS: 5 | US FAERS | |
| 80 | Stress | FAERS: 5 | US FAERS | |
| 81 | Abasia | FAERS: 4 | US FAERS | |
| 82 | Acute kidney injury | FAERS: 4 | US FAERS | |
| 83 | Angina Pectoris | FAERS: 4 | US FAERS | |
| 84 | Crying | FAERS: 4 | US FAERS | |
| 85 | Depressed Level of Consciousness | FAERS: 4 | US FAERS | |
| 86 | Discomfort | FAERS: 4 | US FAERS | |
| 87 | Drug screen false positive | FAERS: 4 | US FAERS | |
| 88 | Dysarthria | FAERS: 4 | US FAERS | |
| 89 | Dysphonia | FAERS: 4 | US FAERS | |
| 90 | Emotional distress | FAERS: 4 | US FAERS | |
| 91 | Erythema | FAERS: 4 | US FAERS | |
| 92 | Head discomfort | FAERS: 4 | US FAERS | |
| 93 | Immunosuppression | FAERS: 4 | US FAERS | |
| 94 | Inappropriate schedule of drug administration | FAERS: 4 | US FAERS | |
| 95 | Infection | FAERS: 4 | US FAERS | |
| 96 | Initial insomnia | FAERS: 4 | US FAERS | |
| 97 | Maternal exposure before pregnancy | FAERS: 4 | US FAERS | |
| 98 | Overdose | FAERS: 4 | US FAERS | |
| 99 | Peripheral swelling | FAERS: 4 | US FAERS | |
| 100 | Polyneuropathy | FAERS: 4 | US FAERS | |
| 101 | Product quality issue | FAERS: 4 | US FAERS | |
| 102 | Product use complaint | FAERS: 4 | US FAERS | |
| 103 | Psychiatric symptom | FAERS: 4 | US FAERS | |
| 104 | Pulmonary Embolism | FAERS: 4 | US FAERS | |
| 105 | Therapeutic response unexpected | FAERS: 4 | US FAERS | |
| 106 | Therapy change | FAERS: 4 | US FAERS | |
| 107 | Transaminases increased | FAERS: 4 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 108 | Accidental overdose | FAERS: 3 | US FAERS | |
| 109 | Anencephaly | FAERS: 3 | US FAERS | |
| 110 | Arthropathy | FAERS: 3 | US FAERS | |
| 111 | Atrial Fibrillation | FAERS: 3 | US FAERS | |
| 112 | Burning sensation | FAERS: 3 | US FAERS | |
| 113 | Cerebral Infarction | FAERS: 3 | US FAERS | |
| 114 | Chemotherapy | FAERS: 3 | US FAERS | |
| 115 | Drug level decreased | FAERS: 3 | US FAERS | |
| 116 | Dysgeusia | FAERS: 3 | US FAERS | |
| 117 | Economic problem | FAERS: 3 | US FAERS | |
| 118 | Eye pain | FAERS: 3 | US FAERS | |
| 119 | Hypertransaminasaemia | FAERS: 3 | US FAERS | |
| 120 | Insurance issue | FAERS: 3 | US FAERS | |
| 121 | Intentional product misuse | FAERS: 3 | US FAERS | |
| 122 | Lip swelling | FAERS: 3 | US FAERS | |
| 123 | Live Birth | FAERS: 3 | US FAERS | |
| 124 | Loss of personal independence in daily activities | FAERS: 3 | US FAERS | |
| 125 | Microcephaly | FAERS: 3 | US FAERS | |
| 126 | Multimorbidity | FAERS: 3 | US FAERS | |
| 127 | Multiple allergies | FAERS: 3 | US FAERS | |
| 128 | Nervousness | FAERS: 3 | US FAERS | |
| 129 | Poor quality sleep | FAERS: 3 | US FAERS | |
| 130 | Product dispensing error | FAERS: 3 | US FAERS | |
| 131 | Product use issue | FAERS: 3 | US FAERS | |
| 132 | Rhabdomyolysis | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 133 | Spina Bifida | FAERS: 3 | US FAERS | |
| 134 | Swelling | FAERS: 3 | US FAERS | |
| 135 | Tachycardia | FAERS: 3 | US FAERS | |
| 136 | Tinnitus | FAERS: 3 | US FAERS | |
| 137 | Toxicity to various agents | FAERS: 3 | US FAERS | |
| 138 | Abdominal Infection | FAERS: 2 | US FAERS | |
| 139 | Acne | FAERS: 2 | US FAERS | |
| 140 | Amnesia | FAERS: 2 | US FAERS | |
| 141 | Amphetamines positive | FAERS: 2 | US FAERS | |
| 142 | Anosmia | FAERS: 2 | US FAERS | |
| 143 | Appendicitis | FAERS: 2 | US FAERS | |
| 144 | Arthropod bite | FAERS: 2 | US FAERS | |
| 145 | Blindness | FAERS: 2 | US FAERS | |
| 146 | Blood creatine increased | FAERS: 2 | US FAERS | |
| 147 | Bowel movement irregularity | FAERS: 2 | US FAERS | |
| 148 | Cataract operation | FAERS: 2 | US FAERS | |
| 149 | Cholelithiasis | FAERS: 2 | US FAERS | |
| 150 | Clinodactyly | FAERS: 2 | US FAERS | |
| 151 | Congenital skin dimples | FAERS: 2 | US FAERS | |
| 152 | Conversion disorder | FAERS: 2 | US FAERS | |
| 153 | Deep Vein Thrombosis | FAERS: 2 | US FAERS | |
| 154 | Dehydration | FAERS: 2 | US FAERS | |
| 155 | Delirium | FAERS: 2 | US FAERS | |
| 156 | Drug administration error | FAERS: 2 | US FAERS | |
| 157 | Drug prescribing error | FAERS: 2 | US FAERS | |
| 158 | Dry skin | FAERS: 2 | US FAERS | |
| 159 | Ear discomfort | FAERS: 2 | US FAERS | |
| 160 | Eczema | FAERS: 2 | US FAERS | |
| 161 | Emergency Care | FAERS: 2 | US FAERS | |
| 162 | Epilepsy | FAERS: 2 | US FAERS | |
| 163 | Epistaxis | FAERS: 2 | US FAERS | |
| 164 | Erectile dysfunction | FAERS: 2 | US FAERS | |
| 165 | Extra dose administered | FAERS: 2 | US FAERS | |
| 166 | Facial wasting | FAERS: 2 | US FAERS | |
| 167 | Fanconi Syndrome | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 168 | Feelings of worthlessness | FAERS: 2 | US FAERS | |
| 169 | Flushing | FAERS: 2 | US FAERS | |
| 170 | Fracture | FAERS: 2 | US FAERS | |
| 171 | Gait inability | FAERS: 2 | US FAERS | |
| 172 | General physical health deterioration | FAERS: 2 | US FAERS | |
| 173 | Gingivitis | FAERS: 2 | US FAERS | |
| 174 | HIV-associated neurocognitive disorder | FAERS: 2 | US FAERS | |
| 175 | HLA marker study positive | FAERS: 2 | US FAERS | |
| 176 | Head circumference abnormal | FAERS: 2 | US FAERS | |
| 177 | Heat illness | FAERS: 2 | US FAERS | |
| 178 | Hepatitis A | FAERS: 2 | US FAERS | |
| 179 | Hepatitis C | FAERS: 2 | US FAERS | |
| 180 | Hepatotoxicity | FAERS: 2 | US FAERS | |
| 181 | Human immunodeficiency virus transmission | FAERS: 2 | US FAERS | |
| 182 | Incorrect dose administered | FAERS: 2 | US FAERS | |
| 183 | Intentional dose omission | FAERS: 2 | US FAERS | |
| 184 | Intentional self-injury | FAERS: 2 | US FAERS | |
| 185 | Irritable Bowel Syndrome | FAERS: 2 | US FAERS | |
| 186 | Joint swelling | FAERS: 2 | US FAERS | |
| 187 | Lipodystrophy acquired | FAERS: 2 | US FAERS | |
| 188 | Lymphoma | FAERS: 2 | US FAERS | |
| 189 | Medication Error | FAERS: 2 | US FAERS | |
| 190 | Mental impairment | FAERS: 2 | US FAERS | |
| 191 | Mental status changes | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 192 | Mitochondrial toxicity | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 193 | Mixed liver injury | FAERS: 2 | US FAERS | |
| 194 | Musculoskeletal stiffness | FAERS: 2 | US FAERS | |
| 195 | Mutism | FAERS: 2 | US FAERS | |
| 196 | Nephrolithiasis | FAERS: 2 | US FAERS | |
| 197 | Neuralgia | FAERS: 2 | US FAERS | |
| 198 | Neutrophil count decreased | FAERS: 2 | US FAERS | |
| 199 | Paraparesis | FAERS: 2 | US FAERS | |
| 200 | Personality Change | FAERS: 2 | US FAERS | |
| 201 | Prescription drug used without a prescription | FAERS: 2 | US FAERS | |
| 202 | Product use in unapproved indication | FAERS: 2 | US FAERS | |
| 203 | Rehabilitation therapy | FAERS: 2 | US FAERS | |
| 204 | Renal pain | FAERS: 2 | US FAERS | |
| 205 | Respiratory Failure | FAERS: 2 | US FAERS | |
| 206 | Respiratory distress | FAERS: 2 | US FAERS | |
| 207 | Retinal Detachment | FAERS: 2 | US FAERS | |
| 208 | Scab | FAERS: 2 | US FAERS | |
| 209 | Sudden death | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 210 | Thrombocytopenia | FAERS: 2 | US FAERS | |
| 211 | Trisomy 21 | FAERS: 2 | US FAERS | |
| 212 | Troponin increased | FAERS: 2 | US FAERS | |
| 213 | Tuberculosis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 214 | Unresponsive to stimuli | FAERS: 2 | US FAERS | |
| 215 | Vertigo | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 216 | Virologic failure | FAERS: 2 | US FAERS | |
| 217 | White blood cell count decreased | FAERS: 2 | US FAERS | |
| 218 | treatment failure | FAERS: 2 | US FAERS | |
| 219 | Abnormal weight gain | FAERS: 1 | US FAERS | |
| 220 | Acquired Immunodeficiency Syndrome | FAERS: 1 | US FAERS | |
| 221 | Acute Coronary Syndrome | FAERS: 1 | US FAERS | |
| 222 | Acute psychosis | FAERS: 1 | US FAERS | |
| 223 | Amino acid level increased | FAERS: 1 | US FAERS | |
| 224 | Amyloidosis | FAERS: 1 | US FAERS | |
| 225 | Angioedema | FAERS: 1 | US FAERS | |
| 226 | Apathy | FAERS: 1 | US FAERS | |
| 227 | Aphasia | FAERS: 1 | US FAERS | |
| 228 | Apparent death | FAERS: 1 | US FAERS | |
| 229 | Arthritis | FAERS: 1 | US FAERS | |
| 230 | Ascites | FAERS: 1 | US FAERS | |
| 231 | Asphyxia | FAERS: 1 | US FAERS | |
| 232 | Ataxia | FAERS: 1 | US FAERS | |
| 233 | Autoimmune hepatitis | FAERS: 1 | US FAERS | |
| 234 | Bedridden | FAERS: 1 | US FAERS | |
| 235 | Bile duct stent insertion | FAERS: 1 | US FAERS | |
| 236 | Bipolar I disorder | FAERS: 1 | US FAERS | |
| 237 | Blood albumin decreased | FAERS: 1 | US FAERS | |
| 238 | Blood alkaline phosphatase increased | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 239 | Blood cannabinoids | FAERS: 1 | US FAERS | |
| 240 | Blood creatine phosphokinase MB increased | FAERS: 1 | US FAERS | |
| 241 | Blood creatinine decreased | FAERS: 1 | US FAERS | |
| 242 | Blood elastase increased | FAERS: 1 | US FAERS | |
| 243 | Blood glucose abnormal | FAERS: 1 | US FAERS | |
| 244 | Blood glucose fluctuation | FAERS: 1 | US FAERS | |
| 245 | Blood potassium decreased | FAERS: 1 | US FAERS | |
| 246 | Blood pressure fluctuation | FAERS: 1 | US FAERS | |
| 247 | Blood pressure inadequately controlled | FAERS: 1 | US FAERS | |
| 248 | Blood urea increased | FAERS: 1 | US FAERS | |
| 249 | Blood urine present | FAERS: 1 | US FAERS | |
| 250 | Body fat disorder | FAERS: 1 | US FAERS | |
| 251 | CD4 lymphocytes abnormal | FAERS: 1 | US FAERS | |
| 252 | Cachexia | FAERS: 1 | US FAERS | |
| 253 | Cardiac Arrest | FAERS: 1 | US FAERS | |
| 254 | Cardiac dysfunction | FAERS: 1 | US FAERS | |
| 255 | Cellulitis | FAERS: 1 | US FAERS | |
| 256 | Central nervous system lesion | FAERS: 1 | US FAERS | |
| 257 | Cerebral disorder | FAERS: 1 | US FAERS | |
| 258 | Chest discomfort | FAERS: 1 | US FAERS | |
| 259 | Cholecystitis | FAERS: 1 | US FAERS | |
| 260 | Cholestasis | FAERS: 1 | US FAERS | |
| 261 | Chromaturia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 262 | Circumstance or information capable of leading to medication error | FAERS: 1 | US FAERS | |
| 263 | Clostridium difficile infection | FAERS: 1 | US FAERS | |
| 264 | Cold sweat | FAERS: 1 | US FAERS | |
| 265 | Colectomy | FAERS: 1 | US FAERS | |
| 266 | Colitis | FAERS: 1 | US FAERS | |
| 267 | Compression fracture | FAERS: 1 | US FAERS | |
| 268 | Contraindicated drug prescribed | FAERS: 1 | US FAERS | |
| 269 | Contraindicated product administered | FAERS: 1 | US FAERS | |
| 270 | Creatinine renal clearance decreased | FAERS: 1 | US FAERS | |
| 271 | Creatinine renal clearance increased | FAERS: 1 | US FAERS | |
| 272 | Deafness | FAERS: 1 | US FAERS | |
| 273 | Debridement | FAERS: 1 | US FAERS | |
| 274 | Dental caries | FAERS: 1 | US FAERS | |
| 275 | Diabetic Ketoacidosis | FAERS: 1 | US FAERS | |
| 276 | Diabetic metabolic decompensation | FAERS: 1 | US FAERS | |
| 277 | Diffuse alopecia | FAERS: 1 | US FAERS | |
| 278 | Diplopia | FAERS: 1 | US FAERS | |
| 279 | Disease Progression | FAERS: 1 | US FAERS | |
| 280 | Disease complication | FAERS: 1 | US FAERS | |
| 281 | Drug abuse | FAERS: 1 | US FAERS | |
| 282 | Drug effect incomplete | FAERS: 1 | US FAERS | |
| 283 | Dysentery | FAERS: 1 | US FAERS | |
| 284 | Dysuria | FAERS: 1 | US FAERS | |
| 285 | Ecchymosis | FAERS: 1 | US FAERS | |
| 286 | Emergency care examination | FAERS: 1 | US FAERS | |
| 287 | Emotional disorder | FAERS: 1 | US FAERS | |
| 288 | Encephalitis | FAERS: 1 | US FAERS | |
| 289 | Eosinophilia | FAERS: 1 | US FAERS | |
| 290 | Epigastric discomfort | FAERS: 1 | US FAERS | |
| 291 | Erythema Nodosum | FAERS: 1 | US FAERS | |
| 292 | Exposure via body fluid | FAERS: 1 | US FAERS | |
| 293 | Exposure via partner | FAERS: 1 | US FAERS | |
| 294 | Eye symptom | FAERS: 1 | US FAERS | |
| 295 | Eye ulcer | FAERS: 1 | US FAERS | |
| 296 | Facial Paresis | FAERS: 1 | US FAERS | |
| 297 | Facial paralysis | FAERS: 1 | US FAERS | |
| 298 | Failure to Thrive | FAERS: 1 | US FAERS | |
| 299 | False positive investigation result | FAERS: 1 | US FAERS | |
| 300 | Feeling jittery | FAERS: 1 | US FAERS | |
| 301 | Food Poisoning | FAERS: 1 | US FAERS | |
| 302 | Fracture treatment | FAERS: 1 | US FAERS | |
| 303 | Full blood count decreased | FAERS: 1 | US FAERS | |
| 304 | Gamma-glutamyltransferase abnormal | FAERS: 1 | US FAERS | |
| 305 | Gastrectomy | FAERS: 1 | US FAERS | |
| 306 | Gastric Bypass | FAERS: 1 | US FAERS | |
| 307 | Gastric infection | FAERS: 1 | US FAERS | |
| 308 | Gastroenteritis norovirus | FAERS: 1 | US FAERS | |
| 309 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 310 | General symptom | FAERS: 1 | US FAERS | |
| 311 | Genital discharge | FAERS: 1 | US FAERS | |
| 312 | Gestational Diabetes | FAERS: 1 | US FAERS | |
| 313 | Gingival Recession | FAERS: 1 | US FAERS | |
| 314 | Guillain-Barre Syndrome | FAERS: 1 | US FAERS | |
| 315 | HIV test false positive | FAERS: 1 | US FAERS | |
| 316 | Haptoglobin Decreased | FAERS: 1 | US FAERS | |
| 317 | Heart sounds abnormal | FAERS: 1 | US FAERS | |
| 318 | Hemiparesis | FAERS: 1 | US FAERS | |
| 319 | Hepatic necrosis | FAERS: 1 | US FAERS | |
| 320 | Hepatitis B | FAERS: 1 | US FAERS | |
| 321 | Hepatosplenomegaly | FAERS: 1 | US FAERS | |
| 322 | Hernia | FAERS: 1 | US FAERS | |
| 323 | Hip surgery | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 324 | Histoplasmosis | FAERS: 1 | US FAERS | |
| 325 | Hospice Care | FAERS: 1 | US FAERS | |
| 326 | Hunger | FAERS: 1 | US FAERS | |
| 327 | Hyperacusis | FAERS: 1 | US FAERS | |
| 328 | Hyperthyroidism | FAERS: 1 | US FAERS | |
| 329 | Hypoxia | FAERS: 1 | US FAERS | |
| 330 | IgM nephropathy | FAERS: 1 | US FAERS | |
| 331 | Implant site extravasation | FAERS: 1 | US FAERS | |
| 332 | Incoherent | FAERS: 1 | US FAERS | |
| 333 | Incorrect product storage | FAERS: 1 | US FAERS | |
| 334 | Intentional product use issue | FAERS: 1 | US FAERS | |
| 335 | Intercepted drug dispensing error | FAERS: 1 | US FAERS | |
| 336 | Intercepted medication error | FAERS: 1 | US FAERS | |
| 337 | Intercepted product administration error | FAERS: 1 | US FAERS | |
| 338 | Intestinal Obstruction | FAERS: 1 | US FAERS | |
| 339 | Joint stiffness | FAERS: 1 | US FAERS | |
| 340 | Ketoacidosis | FAERS: 1 | US FAERS | |
| 341 | Laceration | FAERS: 1 | US FAERS | |
| 342 | Limb discomfort | FAERS: 1 | US FAERS | |
| 343 | Lipohypertrophy | FAERS: 1 | US FAERS | |
| 344 | Lipoprotein (a) increased | FAERS: 1 | US FAERS | |
| 345 | Livedo Reticularis | FAERS: 1 | US FAERS | |
| 346 | Loose tooth | FAERS: 1 | US FAERS | |
| 347 | Lower respiratory tract infection | FAERS: 1 | US FAERS | |
| 348 | Lumbosacral radiculopathy | FAERS: 1 | US FAERS | |
| 349 | Lymphogranuloma Venereum | FAERS: 1 | US FAERS | |
| 350 | Malnutrition | FAERS: 1 | US FAERS | |
| 351 | Mechanical ventilation | FAERS: 1 | US FAERS | |
| 352 | Medication residue present | FAERS: 1 | US FAERS | |
| 353 | Meningitis | FAERS: 1 | US FAERS | |
| 354 | Middle insomnia | FAERS: 1 | US FAERS | |
| 355 | Miller Fisher Syndrome | FAERS: 1 | US FAERS | |
| 356 | Monoparesis | FAERS: 1 | US FAERS | |
| 357 | Mood swings | FAERS: 1 | US FAERS | |
| 358 | Multiple Sclerosis | FAERS: 1 | US FAERS | |
| 359 | Muscle Fatigue | FAERS: 1 | US FAERS | |
| 360 | Muscle tightness | FAERS: 1 | US FAERS | |
| 361 | Musculoskeletal chest pain | FAERS: 1 | US FAERS | |
| 362 | Mycobacterium tuberculosis complex test positive | FAERS: 1 | US FAERS | |
| 363 | Myosclerosis | FAERS: 1 | US FAERS | |
| 364 | Nasal pruritus | FAERS: 1 | US FAERS | |
| 365 | Neck Pain | FAERS: 1 | US FAERS | |
| 366 | Neurosyphilis | FAERS: 1 | US FAERS | |
| 367 | No adverse event | FAERS: 1 | US FAERS | |
| 368 | Nodular melanoma | FAERS: 1 | US FAERS | |
| 369 | Nutritional condition abnormal | FAERS: 1 | US FAERS | |
| 370 | Obesity | FAERS: 1 | US FAERS | |
| 371 | Ocular icterus | FAERS: 1 | US FAERS | |
| 372 | Olfactory Nerve Disorder | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 373 | Onychomycosis | FAERS: 1 | US FAERS | |
| 374 | Optic Neuritis | FAERS: 1 | US FAERS | |
| 375 | Oral mucosal eruption | FAERS: 1 | US FAERS | |
| 376 | Osteogenesis Imperfecta | FAERS: 1 | US FAERS | |
| 377 | Osteopenia | FAERS: 1 | US FAERS | |
| 378 | Oxygen saturation abnormal | FAERS: 1 | US FAERS | |
| 379 | Pancreatic carcinoma | FAERS: 1 | US FAERS | |
| 380 | Paranoia | FAERS: 1 | US FAERS | |
| 381 | Pathogen resistance | FAERS: 1 | US FAERS | |
| 382 | Percutaneous Coronary Intervention | FAERS: 1 | US FAERS | |
| 383 | Pericarditis | FAERS: 1 | US FAERS | |
| 384 | Peripheral artery thrombosis | FAERS: 1 | US FAERS | |
| 385 | Phonophobia | FAERS: 1 | US FAERS | |
| 386 | Photophobia | FAERS: 1 | US FAERS | |
| 387 | Physical disability | FAERS: 1 | US FAERS | |
| 388 | Post procedural complication | FAERS: 1 | US FAERS | |
| 389 | Pressure of speech | FAERS: 1 | US FAERS | |
| 390 | Presyncope | FAERS: 1 | US FAERS | |
| 391 | Proctitis | FAERS: 1 | US FAERS | |
| 392 | Product communication issue | FAERS: 1 | US FAERS | |
| 393 | Product complaint | FAERS: 1 | US FAERS | |
| 394 | Product distribution issue | FAERS: 1 | US FAERS | |
| 395 | Product packaging issue | FAERS: 1 | US FAERS | |
| 396 | Product preparation error | FAERS: 1 | US FAERS | |
| 397 | Product supply issue | FAERS: 1 | US FAERS | |
| 398 | Product tampering | FAERS: 1 | US FAERS | |
| 399 | Productive Cough | FAERS: 1 | US FAERS | |
| 400 | Prostate examination abnormal | FAERS: 1 | US FAERS | |
| 401 | Proteinuria | FAERS: 1 | US FAERS | |
| 402 | Psoriasis | FAERS: 1 | US FAERS | |
| 403 | Pulmonary arterial hypertension | FAERS: 1 | US FAERS | |
| 404 | Pulmonary congestion | FAERS: 1 | US FAERS | |
| 405 | Quadriparesis | FAERS: 1 | US FAERS | |
| 406 | Radiation skin injury | FAERS: 1 | US FAERS | |
| 407 | Renal Colic | FAERS: 1 | US FAERS | |
| 408 | Renal Replacement Therapy | FAERS: 1 | US FAERS | |
| 409 | Renal tubular necrosis | FAERS: 1 | US FAERS | |
| 410 | Respiratory tract congestion | FAERS: 1 | US FAERS | |
| 411 | Restless Legs Syndrome | FAERS: 1 | US FAERS | |
| 412 | Restlessness | FAERS: 1 | US FAERS | |
| 413 | Retroviral rebound syndrome | FAERS: 1 | US FAERS | |
| 414 | Rheumatoid Arthritis | FAERS: 1 | US FAERS | |
| 415 | Rift Valley Fever | FAERS: 1 | US FAERS | |
| 416 | Salivary gland pain | FAERS: 1 | US FAERS | |
| 417 | Schizophrenia | FAERS: 1 | US FAERS | |
| 418 | Sciatica | FAERS: 1 | US FAERS | |
| 419 | Secretion discharge | FAERS: 1 | US FAERS | |
| 420 | Shock | FAERS: 1 | US FAERS | |
| 421 | Sinusitis | FAERS: 1 | US FAERS | |
| 422 | Skin Ulcer | FAERS: 1 | US FAERS | |
| 423 | Skin lesion | FAERS: 1 | US FAERS | |
| 424 | Skin necrosis | FAERS: 1 | US FAERS | |
| 425 | Skin reaction | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 426 | Sluggishness | FAERS: 1 | US FAERS | |
| 427 | Sneezing | FAERS: 1 | US FAERS | |
| 428 | Spinal fusion surgery | FAERS: 1 | US FAERS | |
| 429 | Splenomegaly | FAERS: 1 | US FAERS | |
| 430 | Stevens-Johnson Syndrome | FAERS: 1 | US FAERS | |
| 431 | Stress at work | FAERS: 1 | US FAERS | |
| 432 | Sunburn | FAERS: 1 | US FAERS | |
| 433 | Supportive care | FAERS: 1 | US FAERS | |
| 434 | Teeth brittle | FAERS: 1 | US FAERS | |
| 435 | Temperature intolerance | FAERS: 1 | US FAERS | |
| 436 | Tension Headache | FAERS: 1 | US FAERS | |
| 437 | Thrombocytopenic purpura | FAERS: 1 | US FAERS | |
| 438 | Thrombosis | FAERS: 1 | US FAERS | |
| 439 | Toxoplasmosis | FAERS: 1 | US FAERS | |
| 440 | Upper-airway cough syndrome | FAERS: 1 | US FAERS | |
| 441 | Urethral discharge | FAERS: 1 | US FAERS | |
| 442 | Vascular pain | FAERS: 1 | US FAERS | |
| 443 | Venous Thrombosis | FAERS: 1 | US FAERS | |
| 444 | Viral load decreased | FAERS: 1 | US FAERS | |
| 445 | Viral load undetectable | FAERS: 1 | US FAERS | |
| 446 | Viral mutation identified | FAERS: 1 | US FAERS | |
| 447 | Viral upper respiratory tract infection | FAERS: 1 | US FAERS | |
| 448 | Visual Impairment | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 449 | Waist circumference increased | FAERS: 1 | US FAERS | |
| 450 | Wheezing | FAERS: 1 | US FAERS | |
| 451 | Xerophthalmia | FAERS: 1 | US FAERS | |
| 452 | pH urine decreased | FAERS: 1 | US FAERS | |
| 453 | Clumsiness | Canada Vigilance: 1 | Canada Vigilance | |
| 454 | Exfoliative rash | Canada Vigilance: 1 | Canada Vigilance | |
| 455 | Gamma-Glutamyltransferase Increased | Canada Vigilance: 1 | Canada Vigilance | |
| 456 | Product substitution issue | Canada Vigilance: 3 | Canada Vigilance | |
| 457 | Thirst | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.